Paclitaxel nanoparticles potent as second-line therapy in phase II trial in metastatic UC March 22, 2010
Chugai seeks Japanese approval for Herceptin in combination with Xeloda for gastric cancer March 22, 2010
Vorinostat exhibits safety and tolerability in phase II trial in advanced renal cell carcinoma March 22, 2010
RSS